1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat

Diagnostics guidance [DG10] Published date: September 2013

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Recommendations
  • 2 The technologies
  • 3 Clinical need and practice
  • 4 The diagnostic tests
  • 5 Outcomes
  • 6 Considerations
  • 7 Recommendations for further research
  • 8 Implementation
  • 9 Related NICE guidance
  • 10 Review
  • 11 Diagnostics Advisory Committee members and NICE project team
  • 12 Sources of evidence considered by the Committee
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download
    • Save
    • Save as PDF
    • Save as ePub
    • Save as eBook

Guidance

  • Next

9 Related NICE guidance

9 Related NICE guidance

See www.nice.org.uk for related guidance.

  • National Institute for Health and Care Excellence (NICE)

  • Next
NICE
  • About NICE
  • Into practice
  • News
  • Contact us
  • Leave feedback
  • Jobs
  • Newsletters and alerts
  • Blog
  • Twitter
  • YouTube
  •   Facebook
  • LinkedIn

Explore

  • Guidance
  • Pathways
  • Standards and indicators
  • Savings and productivity
  • Evidence search
  • BNF
  • BNFC
  • Clinical knowledge summaries
  • Journals and databases

Reusing our content

  • Reuse information
  • NICE UK Open Content Licence

Guidance app

  • Android
  • iOS

Get involved

  • Register as a stakeholder
  • Citizens council
  • Consultations
  • Fellows and scholars
  • Join a committee
  • Meetings in public
  • Student champions
  • Tenders
  • Public involvement
  • Accessibility
  • Freedom of information
  • Syndication services
  • Glossary
  • Terms and conditions

Copyright © 2017 National Institute for Health and Care Excellence. All rights reserved.